LVCLY
Price:
$0.0306
Market Cap:
$24.53M
Living Cell Technologies Limited (LCT) is a biotechnology company dedicated to the innovation, development, and market introduction of regenerative medical therapies. These treatments leverage naturally occurring cells with the aim of restoring physiological functions, particularly within New Zealand. A primary focus for LCT is NTCELL, a novel alginate-coated capsule currently progressing through Phase IIb clinical trials for its application in treating Parkinson's disease. The company was founded in 1987 and operates from its base in Sydney, Australia.
Industry
Biotechnology
IPO Date
2008-01-30
Stock Exchange
OTC
Ticker
LVCLY
According to Living Cell Technologies Limited’s latest financial reports and current stock price. The company's current PE Ratio is -3.06. This represents a change of -49.42% compared to the average of -6.05 of the last 4 quarters.
The mean historical PE Ratio of Living Cell Technologies Limited over the last ten years is -11.27. The current -3.06 PE Ratio has changed 2.61% with respect to the historical average. Over the past ten years (40 quarters), LVCLY's PE Ratio was at its highest in in the June 2018 quarter at 2.28. The PE Ratio was at its lowest in in the December 2012 quarter at -17.15.
Average
-11.27
Median
-8.54
Minimum
-40.42
Maximum
-3.03
Discovering the peaks and valleys of Living Cell Technologies Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 274.68%
Maximum Annual PE Ratio = -3.03
Minimum Annual Increase = -88.70%
Minimum Annual PE Ratio = -40.42
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -12.32 | 28.49% |
| 2023 | -9.59 | 164.54% |
| 2022 | -3.62 | -27.15% |
| 2021 | -4.97 | -33.69% |
| 2020 | -7.50 | 64.25% |
| 2019 | -4.57 | -88.70% |
| 2018 | -40.42 | 162.86% |
| 2017 | -15.38 | 35.48% |
| 2016 | -11.35 | 274.68% |
| 2015 | -3.03 | 6.44% |
The current PE Ratio of Living Cell Technologies Limited (LVCLY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-8.51
5-year avg
-7.60
10-year avg
-11.27
Living Cell Technologies Limited’s PE Ratio is greater than Avecho Biotechnology Limited (-8.53), greater than Ceapro Inc. (-3.74), less than Eiger BioPharmaceuticals, Inc. (-0.17), less than Poxel S.A. (-0.78), less than Bionomics Limited (-0.86), less than Rapid Dose Therapeutics Corp. (-2.71), less than Antibe Therapeutics Inc. (-0.79), less than LexaGene Holdings Inc. (0), less than Verici Dx plc (-0.18), greater than Noxopharm Limited (-4.10),
| Company | PE Ratio | Market cap |
|---|---|---|
| -8.53 | $13.35M | |
| -3.74 | $13.31M | |
| -0.17 | $12.59M | |
| -0.78 | $15.88M | |
| -0.86 | $8.81M | |
| -2.71 | $8.90M | |
| -0.79 | $11.43M | |
| 0 | $11.34M | |
| -0.18 | $4.54M | |
| -4.10 | $14.78M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Living Cell Technologies Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Living Cell Technologies Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Living Cell Technologies Limited's PE Ratio?
How is the PE Ratio calculated for Living Cell Technologies Limited (LVCLY)?
What is the highest PE Ratio for Living Cell Technologies Limited (LVCLY)?
What is the 3-year average PE Ratio for Living Cell Technologies Limited (LVCLY)?
What is the 5-year average PE Ratio for Living Cell Technologies Limited (LVCLY)?
How does the current PE Ratio for Living Cell Technologies Limited (LVCLY) compare to its historical average?